Published in Blood Weekly, December 30th, 2004
"Heparin is frequently used in preterm infants to prolong the patency of intravascular catheters," according to physicians in Chicago, who conducted a study "to evaluate the prevalence of heparin-dependent platelet-activating antibodies in newborns."
"A cross-section of all preterm newborn infants expected to require heparin to maintain patency of a central venous access line were enrolled," explained P. Kumar and colleagues at Northwestern Memorial Hospital. "A blood sample was obtained soon after birth before heparin exposure to exclude the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.